Neuroprotection in Autism, Schizophrenia and Alzheimer's disease
Editat de Illana Gozes, Joseph Levineen Limba Engleză Paperback – 16 oct 2019
- Offers an up-to-date overview of basic and clinical studies concerning similarities in the most prevalent brain disorders
- Helps the reader become familiar with novel neuroprotective mechanisms and experimental treatment modalities in these difficult to treat disorders
- Written for researchers, clinicians and medical physicians in neuroscience, neurology and psychiatry
Preț: 686.83 lei
Preț vechi: 877.18 lei
-22% Nou
Puncte Express: 1030
Preț estimativ în valută:
131.44€ • 137.05$ • 109.24£
131.44€ • 137.05$ • 109.24£
Carte tipărită la comandă
Livrare economică 14-28 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128140376
ISBN-10: 0128140372
Pagini: 322
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0128140372
Pagini: 322
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
Public țintă
researchers, clinicians, and medical physicians in neuroscience, neurology, and psychiatryCuprins
Section I. Overview
1. Activity-dependent neuroprotective protein (ADNP)/NAP (CP201): autism, schizophrenia and Alzheimer’s disease
2. Clinical convergence of autism, schizophrenia and Alzheimer’s disease: The case of social cognition
Section II. Autism
3. A contemporary view on the molecular basis of neurodevelopmental disorders
4. Autism spectrum disorder - A clinical path to early diagnosis, evaluation and intervention
5. Neuro-inflammation and neuroprotection in schizophrenia and autism spectrum disorder
Section III. Neuropsychiatric Disorders
6. Neuroprotective roles of neurotrophic factors in depression
7. Neuroprotective roles of neurotrophic growth factors in mood disorders
8. Heme metabolism, mitochondria and complex I in neuropsychiatric disorders
9. Neuroprotective effects of lithium in neuropsychiatric disorders
Section IV. Alzheimer and Neurodegenerative Diseases
10. Tau-based therapies for Alzheimer´s disease: promising novel neuroprotective approaches
11. Acetylation of tubulin: a feasible protective target from neurodevelopment to neurodegeneration?
1. Activity-dependent neuroprotective protein (ADNP)/NAP (CP201): autism, schizophrenia and Alzheimer’s disease
2. Clinical convergence of autism, schizophrenia and Alzheimer’s disease: The case of social cognition
Section II. Autism
3. A contemporary view on the molecular basis of neurodevelopmental disorders
4. Autism spectrum disorder - A clinical path to early diagnosis, evaluation and intervention
5. Neuro-inflammation and neuroprotection in schizophrenia and autism spectrum disorder
Section III. Neuropsychiatric Disorders
6. Neuroprotective roles of neurotrophic factors in depression
7. Neuroprotective roles of neurotrophic growth factors in mood disorders
8. Heme metabolism, mitochondria and complex I in neuropsychiatric disorders
9. Neuroprotective effects of lithium in neuropsychiatric disorders
Section IV. Alzheimer and Neurodegenerative Diseases
10. Tau-based therapies for Alzheimer´s disease: promising novel neuroprotective approaches
11. Acetylation of tubulin: a feasible protective target from neurodevelopment to neurodegeneration?